All News

Healthcare workers face a potential silent killer every day that is so common it is routinely overlooked and ignored: accidental needlesticks.

Officials with the US FDA have approved a vaccine for use in children younger than age 5 that is indicated for immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Vaxelisâ„¢).

More than 702,000 Americans died from drug overdoses from 1999 to 2017–about 10% of them in 2017 alone, according to findings from an in-depth CDC analysis of the latest available drug overdose death data from the National Center for Health Statistics.

Women between the ages of 30 and 39 who have at least 1 of 3 breast cancer risk factors may benefit from starting their annual mammography screening at age 30

Officials with Neos Therapeutics, Inc., have announced that they have entered into a confidential settlement and licensing agreement with Teva Pharmaceuticals USA

The FDA has approved calaspargase pegol-mknl (Asparlas, Servier Pharmaceuticals) as a component of a multi-agent chemotherapeutic regimen for acute lymphoblastic leukemia (ALL) in patients aged 1 month to 21 years.

Don’t let a busy holiday season distract you from managing your health and staying safe

Officials with the FDA have approved romiplostim (NPLATE, Amgen) for the treatment of immune thrombocytopenia (ITP) in pediatric patients aged 1 year and older.

Fentanyl topped the list of the the 10 most frequently mentioned drugs cited as in connection with drug overdoses, according to a new report from the CDC.

In the 1970s, investigators discovered that Eskimos, particularly Greenland Inuit, and other populations, such as the Japanese, had very low rates of myocardial infarction and other coronary events, despite consuming large amounts of fat derived from fish.

The FDA has approved Mayne Pharma Group Limited’s New Drug Application for SUBA-itraconazole (Tolsura) 65mg capsules.

Hormone therapy is still the most effective means of treating either vasomotor symptoms or the genito-urinary syndrome of menopause.

Getting an annual influenza vaccine may help save heart failure patients’ lives, according to data published in the American Heart Association’s journal Circulation.

Statins have demonstrated substantial benefits in reducing heart attacks and stroke risk caused by blood clots in at-risk patients, and their benefits for most people outweigh the risks, according to a statement this week from the American Heart Association.

Officials with Mylan Pharmaceuticals today announced that they are expanding a consumer-level voluntary nationwide recall to include all lots of valsartan-containing products within expiry.

The US Food and Drug Administration (FDA) has approved Dextenza, a dexamethasone ophthalmic insert, for intracanalicular use for the treatment of ocular pain following ophthalmic surgery.

The campaign promotes HIV prevention awareness and destigmatizes those living with the virus.

CVS Health announced that it has closed its acquisition of Aetna with the promise to transform the consumer health experience.

Diabetic ulcers commonly result from high blood sugar damaging nerves, which takes away feeling from the toes or feet.

New research suggests that hepatitis C virus treatments can be shortened in half of patients receiving them without compromising efficacy, potentially leading to significant cost savings.

Patients with complex health issues and frequent hospital visits, are becoming a focus of care management programs in an effort to improve patient outcomes.

An updated campaign sheds light on the fact that more than millions of Americans may be living with prediabetes, and urges them to find out whether they have prediabetes through discussions with their health care providers.

Investigators found that communication from pediatric providers about high blood pressure was direct in 16.6%, unclear in 16.6%, minimized in 13%, and absent in 66.7% of recorded visits.

An infectious diseases (ID) specialist should be consulted before patients receive intravenous (IV) antimicrobial infusion therapy outside of the hospital, suggest updated guidelines released by the Infectious Diseases Society of America (IDSA) and published in the journal Clinical Infectious Diseases.

Patient nonadherence to prescribed medications is associated with poor therapeutic outcomes, progression of disease, increased healthcare utilization, and an estimated burden of billions per year in avoidable direct healthcare costs.

Officials with the FDA have approved Theravance Biopharma and Mylan’s revefenacin (Yupelri) inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), according to a press release.1

Officials with the US FDA this week announced an emergency use authorization (EUA) for a rapid, single-use test for the detection of Zaire ebolavirus, making it the second Ebola rapid antigen fingerstick test available under EUA, but the first that uses a portable battery-operated reader.

A recent study found that LAIV was more effective in those vaccinated in both the enrollment season and the prior season than in those vaccinated only in the enrollment season.

The FDA has issued a warning to patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, as well as authorized generic versions, may block access to the auto-injector.